• Overview
  • News
  • Analysis
  • Recos
  • Financials
  • Technicals
  • Peers
  • Shareholdings
  • MF
  • Corp Actions
  • About

Insights

View All

  • Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)

  • Company witnessed QoQ revenue decline of 43.32%, which is lowest in the last 3 years. (Source: Standalone Financials)

  • Stock gave a 3 year return of 59.89% as compared to Nifty Smallcap 100 which gave a return of 32.92%. (as of last trading session)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 22.04% towards employee cost in the year ending Mar 31, 2020. (Source: Standalone Financials)

InsightsLotus Eye Hospital and Institute Ltd.

  • Contingent Liabilities Coverage

    Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)

  • Quarterly Topline Performance

    Company witnessed QoQ revenue decline of 43.32%, which is lowest in the last 3 years. (Source: Standalone Financials)

  • Stock Returns vs Nifty Smallcap 100

    Stock gave a 3 year return of 59.89% as compared to Nifty Smallcap 100 which gave a return of 32.92%. (as of last trading session)

  • Employee & Interest Expense

    Company has spent less than 1% of its operating revenues towards interest expenses and 22.04% towards employee cost in the year ending Mar 31, 2020. (Source: Standalone Financials)

Do you find these insights useful?

  • hate it

  • meh

  • love it

Key Metrics

  • 46.51
  • 0.98
  • 95.14
  • 19
  • 1.77
  • 1.10
  • 10.00
  • 2.05
  • 44.68

Returns

  • 1 Day4.58%
  • 1 Week3.87%
  • 1 Month1.0%
  • 3 Months5.31%
  • 1 Year53.19%
  • 3 Years67.22%
  • 5 Years195.47%

Lotus Eye Hosp Stock Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

NO RATING (NR)

NEGATIVE (1-3)

NEUTRAL (4-7)

POSITIVE (8-10)

In-depth Reports on 4000+ Indian Stocks worth ₹1,499 with ET Prime membership

START FREE TRIAL

Recommendations

Financials

  • Income (P&L)

  • Balance Sheet

  • Cash Flow

  • Ratios

  • Insights

    • Quarterly Topline Performance

      Company witnessed QoQ revenue decline of 43.32%, which is lowest in the last 3 years. (Source: Standalone Financials)
    • Employee & Interest Expense

      Company has spent less than 1% of its operating revenues towards interest expenses and 22.04% towards employee cost in the year ending Mar 31, 2020. (Source: Standalone Financials)
    Quarterly | AnnualJun 2021Mar 2021Dec 2020Sep 2020Jun 2020
    Total Income6.1010.7510.077.394.89
    Total Income Growth (%)-43.326.7636.2551.11-41.69
    Total Expenses6.289.398.807.315.56
    Total Expenses Growth (%)-33.086.7320.3531.54-42.48
    EBIT-0.191.361.280.08-0.67
    EBIT Growth (%)-113.806.951,440.34--
    Profit after Tax (PAT)-0.201.111.050.08-0.67
    PAT Growth (%)-117.775.091,261.11--
    EBIT Margin (%)-3.0912.6812.661.12-13.59
    Net Profit Margin (%)-3.2310.3010.461.05-13.69
    Basic EPS (₹)-0.090.530.510.04-0.32
    Quarterly | Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Total Revenue41.4539.1038.8934.6831.71
    Total Revenue Growth (%)6.010.5612.139.384.53
    Total Expenses39.3138.4737.2334.2331.74
    Total Expenses Growth (%)2.163.368.767.85-2.60
    Profit after Tax (PAT)1.060.711.750.440.10
    PAT Growth (%)50.35-59.46293.40340.48-
    Operating Profit Margin (%)5.471.804.501.510.17
    Net Profit Margin (%)2.621.844.591.300.32
    Basic EPS (₹)0.510.330.840.210.05

    All figures in Rs Cr, unless mentioned otherwise

    No reported Profit & Loss Statement are available.

  • Insights

    • Contingent Liabilities Coverage

      Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)
    Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Total Assets58.4456.6558.2154.9454.83
    Total Assets Growth (%)3.16-2.685.950.20-2.82
    Total Liabilities7.196.537.584.885.34
    Total Liabilities Growth (%)10.11-13.8555.33-8.61-24.04
    Total Equity51.2650.1250.6450.0549.48
    Total Equity Growth (%)2.27-1.031.181.150.20
    Current Ratio (x)1.751.101.161.611.38
    Total Debt to Equity (x)0.000.000.010.010.01
    Contingent Liabilities0.900.290.310.310.07

    All figures in Rs Cr, unless mentioned otherwise

    No reported Balance Sheet are available.

  • Insights

    • Decrease in Cash from Investing

      Company has used Rs 0.53 cr for investing activities which is an YoY decrease of 86.89%. (Source: Standalone Financials)
    Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Net Cash flow from Operating Activities4.814.205.782.973.34
    Net Cash used in Investing Activities-0.53-4.01-3.86-1.06-0.85
    Net Cash flow from Financing Activities0.13-1.41-1.51-0.25-0.54
    Net Cash Flow4.42-1.220.411.661.96
    Closing Cash & Cash Equivalent7.022.593.813.402.47
    Closing Cash & Cash Equivalent Growth (%)170.61-31.9912.0837.51379.77
    Total Debt/ CFO (x)0.000.020.050.160.14

    All figures in Rs Cr, unless mentioned otherwise

    No reported Cash Flow Statement are available.

  • Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Return on Equity (%)2.071.413.440.880.20
    Return on Capital Employed (%)4.231.363.341.010.10
    Return on Assets (%)1.821.243.000.800.18
    Interest Coverage Ratio (x)31.4710.7632.278.010.64
    Asset Turnover Ratio (x)69.3867.8265.3161.8256.78
    Price to Earnings (x)45.6665.3633.33175.44333.33
    Price to Book (x)0.950.921.151.540.67
    EV/EBITDA (x)8.7911.6110.7418.696.94
    EBITDA Margin (%)11.629.7613.3711.6414.41

    No reported Financial Ratios are available.

Financial InsightsLotus Eye Hospital and Institute Ltd.

  • Income (P&L)
  • Balance Sheet
  • Cash Flow
    • Quarterly Topline Performance

      Company witnessed QoQ revenue decline of 43.32%, which is lowest in the last 3 years. (Source: Standalone Financials)

    • Employee & Interest Expense

      Company has spent less than 1% of its operating revenues towards interest expenses and 22.04% towards employee cost in the year ending Mar 31, 2020. (Source: Standalone Financials)

    • Contingent Liabilities Coverage

      Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)

    • Decrease in Cash from Investing

      Company has used Rs 0.53 cr for investing activities which is an YoY decrease of 86.89%. (Source: Standalone Financials)

Do you find these insights useful?

  • hate it

  • meh

  • love it

Technicals

  • Buy / Sell Signals

  • Price Analysis

  • Pivot Levels & ATR

  • Chart

  • Stock doesnt have any Buy/Sell Signals.

  • Price Analysis Data details are not available.

  • Pivot Levels

    R1R2R3PIVOTS1S2S3
    Classic-------

    Average True Range

    5 DAYS14 DAYS28 DAYS
    ATR---

Peer Comparison

  • Stock Performance

  • Ratio Performance

    • CHART
    • TABLE

    Insights

    • Stock Returns vs Nifty Smallcap 100

      Stock gave a 3 year return of 59.89% as compared to Nifty Smallcap 100 which gave a return of 32.92%. (as of last trading session)
    • Stock Returns vs S&P BSE Healthcare

      Stock generated 59.89% return as compared to S&P BSE Healthcare which gave investors 64.49% return over 3 year time period. (as of last trading session)
    • 1D
    • 1W
    • 1M
    • 3M
    • 6M
    • 1Y
    • 5Y
  • Insights

    • Stock Returns vs Nifty Smallcap 100

      Stock gave a 3 year return of 59.89% as compared to Nifty Smallcap 100 which gave a return of 32.92%. (as of last trading session)
    • Stock Returns vs S&P BSE Healthcare

      Stock generated 59.89% return as compared to S&P BSE Healthcare which gave investors 64.49% return over 3 year time period. (as of last trading session)

    Ratio Performance

    NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
    Lotus Eye Hosp46.511.852.074.231.826.075.472.620.511.750.000.00
    Max Healthcare113.6229.192.236.611.114.2310.282.450.520.880.656.32
    Fortis Healthcare65.323.23-1.791.61-0.98-4.593.98-2.57-1.450.840.192.36
    Aster DM Health39.732.854.385.861.268.485.752.022.971.140.571.22
    Narayana Hruday59.419.62-1.271.29-0.514.271.03-0.28-0.700.950.471.70
    Add More

    Annual Ratios (%)

    Choose from Peers

    • Krishna Institute of Medical Sciences Ltd.
    • Healthcare Global
    • Shalby
    • Kovai Medical
    • Indraprastha Med

    See All Parameters

Peers InsightsLotus Eye Hospital and Institute Ltd.

  • Stock Returns vs Nifty Smallcap 100

    Stock gave a 3 year return of 59.89% as compared to Nifty Smallcap 100 which gave a return of 32.92%. (as of last trading session)

  • Stock Returns vs S&P BSE Healthcare

    Stock generated 59.89% return as compared to S&P BSE Healthcare which gave investors 64.49% return over 3 year time period. (as of last trading session)

Do you find these insights useful?

  • hate it

  • meh

  • love it

Shareholding Pattern

  • QOQ Change

  • Total Shareholdings

  • Showing Shareholding as on 30 Jun 2021

    Category30 Jun 202131 Mar 202131 Dec 202030 Sep 2020
    Promoters57.7457.7457.7157.68
    Pledge0.000.000.000.00
    FII0.000.000.000.00
    DII0.000.000.000.00
    Mutual Funds0.000.000.000.00
    Others42.2642.2642.2942.32
  • Showing Shareholding as on 30 Jun 2021

    CategoryNo. of SharesPercentage% Change QoQ
    Promoters1,20,07,73957.74 %0.00
    Pledge00.00 %0.00
    DII8,3120.04 %-
    Others87,80,27942.26 %0.00

MF Ownership

MF Ownership details are not available.

Top Searches:

Corporate Actions

  • Board Meeting/AGM

  • Dividends

  • Others
  • Meeting DateAnnounced onPurposeDetails
    Aug 14, 2021Aug 13, 2021Board MeetingQuarterly Results
    Jun 30, 2021Jun 22, 2021Board MeetingAudited Results & Final Dividend
    Feb 09, 2021Jan 18, 2021Board MeetingQuarterly Results
    Nov 28, 2020Nov 06, 2020AGMBook closure from 23 Nov, 2020 to 28 Nov, 2020
    Nov 11, 2020Oct 26, 2020Board MeetingQuarterly Results
  • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
    Final5%0.5Sep 08, 2021Jun 30, 2021
    Final5%0.5Sep 14, 2018May 29, 2018
    Final5%0.5Aug 02, 2017Jul 17, 2017
  • No other corporate actions details are available.

About Lotus Eye Hosp

Lotus Eye Hospital and Institute Ltd., incorporated in the year 1997, is a Small Cap company (having a market cap of Rs 94.94 Crore) operating in Hospitals & Allied Services sector. Lotus Eye Hospital and Institute Ltd. key Products/Revenue Segments include Services (Medical), Contact Lens & Opticals, Pharmaceuticals and Utilities for the year ending 31-Mar-2020. Show More

  • Executives

  • Auditors

  • KS

    K S Ramalingam

    Chief Executive Officer

    SS

    Sangeetha Sundaramoorthy

    Whole Time Director

    KS

    Kavetha Sundaramoorthy

    Director

    Show More

Address

S.F No.770/12,Avinashi Road,Civil Aerodrome Post,Coimbatore, Tamil Nadu - 641014

More Details

Lotus Eye Hosp Share Price Update

Lotus Eye Hospital and Institute Ltd. share price moved up by 4.58% from its previous close of Rs 43.65. Lotus Eye Hospital and Institute Ltd. stock last traded price is 45.65

Share PriceValue
Today/Current/Last45.65
Previous Day43.65

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

Tell us about you

Find us at the office

Eastmond- Sukel street no. 62, 79540 Hanga Roa, Easter Island

Give us a ring

Jaquelinee Wrate
+74 201 709 645
Mon - Fri, 9:00-15:00

Reach out